Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery

January 13, 2022 Business Services

Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …
News

Abivax receive EMA scientific advice support for ulcerative colitis trial

January 13, 2022 Business Services

Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …
News

Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China

January 13, 2022 Business Services

Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …
News

PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance

January 13, 2022 Business Services

The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …
News

FDA grant Breakthrough Therapy Designation to telisotuzumab vedotin

January 6, 2022 Business Services

AbbVie’s investigational telisotuzumab vedotin has been granted Breakthrough Therapy Designation by the FDA for the treatment of patients with advanced …
News

Cyclenium Pharma and Vuja De Sciences collaborate on oncology drug discovery

January 6, 2022 Business Services

Cyclenium Pharma, an emerging pharmaceutical company, have announced a collaboration with Vuja De Sciences, to screen and optimise lead candidates …
News

FDA grants regenerative medicine advanced therapy designation to AlloVir’s posoleucel

January 6, 2022 Business Services

The FDA has granted AlloVir’s posoleucel Regenerative Medicine Advanced Therapy Designation (RMAT), for the treatment of adenovirus infections in adults …
News

Jazz Pharmeuticals announces Phase III data of idiopathic hypersomnia treatment

January 6, 2022 Business Services

Jazz Pharmaceuticals have announced that positive data, from the Phase III of Xywav oral solution for the treatment of adults …
News

Veklury demonstrates reduced risk of hospitalisation in high-risk patients with COVID-19

December 23, 2021 Business Services

Gilead Sciences have announced full results from a Phase III investigational study, evaluating the efficacy and safety of a three-day …
News

Omicron grows 70 times faster than Delta in bronchial tissue

December 16, 2021 Business Services

The COVID-19 variant, Omicron, has been found to replicate around 70 times faster than the original and Delta variants of …
News

Potential drugs for AMD treatment identified using stem-cell based research

December 16, 2021 Business Services

Researchers at the National Institutes of Health (NIH) have identified two drug candidates to slow dry age-related macular degeneration (AMD), …
News

FDA pauses several trials of Merck’s investigational HIV drug

December 16, 2021 Business Services

The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …
News

European Commission backs Johnson & Johnson COVID-19 booster for adults

December 16, 2021 Business Services

The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment

Novartis announces positive results from Phase III trial of Beovu

December 9, 2021 Business Services

Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025